Literature DB >> 19416677

The Alzheimer's disease mitochondrial cascade hypothesis: an update.

Russell H Swerdlow1, Shaharyar M Khan.   

Abstract

In 2004 we proposed the mitochondrial cascade hypothesis of sporadic Alzheimer's disease (AD). Our hypothesis assumed sporadic and autosomal dominant AD are not etiologically homogeneous, considered evidence that AD pathology is not brain-limited, and incorporated aging theory. The mitochondrial cascade hypothesis asserted: (1) inheritance determines mitochondrial baseline function and durability; (2) mitochondrial durability influences how mitochondria change with age; and (3) when mitochondrial change reaches a threshold, AD histopathology and symptoms ensue. We now review the reasoning used to formulate the hypothesis, discuss pertinent interim data, and update its tenants. Readers are invited to consider the conceptual strengths and weaknesses of this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416677      PMCID: PMC2710413          DOI: 10.1016/j.expneurol.2009.01.011

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  131 in total

Review 1.  Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?

Authors:  Michelangelo Mancuso; Fabio Coppedè; Luigi Murri; Gabriele Siciliano
Journal:  Antioxid Redox Signal       Date:  2007-10       Impact factor: 8.401

2.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

3.  Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?

Authors:  S J Kish; F Mastrogiacomo; M Guttman; Y Furukawa; J W Taanman; S Dozić; M Pandolfo; J Lamarche; L DiStefano; L J Chang
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

4.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

5.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

6.  Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.

Authors:  David K Simon; Michael T Lin; Leiya Zheng; Guang-Jun Liu; Colette H Ahn; Lauren M Kim; William M Mauck; Florence Twu; M Flint Beal; Donald R Johns
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

7.  Senile amyloidosis: principles of localization in a heterogeneous form of amyloidosis.

Authors:  S Störkel; J Bohl; H M Schneider
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

Review 8.  GSK3beta signalling: casting a wide net in Alzheimer's disease.

Authors:  Ratan V Bhat; Samantha L Budd
Journal:  Neurosignals       Date:  2002 Sep-Oct

9.  Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes.

Authors:  H Yamaguchi; T Yamazaki; K Ishiguro; M Shoji; Y Nakazato; S Hirai
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.

Authors:  Odity Mukherjee; John S K Kauwe; Kevin Mayo; John C Morris; Alison M Goate
Journal:  BMC Genet       Date:  2007-01-31       Impact factor: 2.797

View more
  93 in total

1.  Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neurobiol Dis       Date:  2011-09-13       Impact factor: 5.996

2.  Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.

Authors:  Jia Yao; Ronald Irwin; Shuhua Chen; Ryan Hamilton; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2011-04-22       Impact factor: 4.673

3.  A comprehensive genetic association study of Alzheimer disease in African Americans.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; Jacki Buros; Robert C Green; Rodney C P Go; Patrick Griffith; Thomas O Obisesan; Rhonna Shatz; Amy Borenstein; L Adrienne Cupples; Kathryn L Lunetta; M Daniele Fallin; Clinton T Baldwin; Lindsay A Farrer
Journal:  Arch Neurol       Date:  2011-12

Review 4.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 5.  Calcium and mitochondrial reactive oxygen species generation: how to read the facts.

Authors:  Vera Adam-Vizi; Anatoly A Starkov
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin.

Authors:  Ravindar R Thomas; Shaharyar M Khan; Francisco R Portell; Rafal M Smigrodzki; James P Bennett
Journal:  Mitochondrion       Date:  2010-08-18       Impact factor: 4.160

Review 8.  Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.

Authors:  Fei Yin; Harsh Sancheti; Zhigang Liu; Enrique Cadenas
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

9.  Determination of Aerobic Capacity via Cycle Ergometer Exercise Testing in Alzheimer's Disease.

Authors:  Ulf G Bronas; Dereck Salisbury; Kaitlin Kelly; Arthur Leon; Lisa Chow; Fang Yu
Journal:  Am J Alzheimers Dis Other Demen       Date:  2017-07-18       Impact factor: 2.035

Review 10.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.